232 related articles for article (PubMed ID: 36746736)
1. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
[TBL] [Abstract][Full Text] [Related]
2. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
[TBL] [Abstract][Full Text] [Related]
3. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
4. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
[TBL] [Abstract][Full Text] [Related]
5. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Purser MF; Mladsi DM; Beckman A; Barion F; Forsey J
Adv Ther; 2018 Oct; 35(10):1686-1696. PubMed ID: 30143957
[TBL] [Abstract][Full Text] [Related]
6. Patterns of utilization and cost of healthcare services and pharmacotherapy among patients with drug-resistant epilepsy during the two-year period before neurostimulation: A descriptive analysis of the journey to implantation based on analyses of a large United States healthcare claims database.
Evans K; Stamas N; Li Q; Vincent T; Zhang L; Danielson V; Lam S; Lassagne R; Berger A
Epilepsy Behav; 2023 Aug; 145():109288. PubMed ID: 37348410
[TBL] [Abstract][Full Text] [Related]
7. Effect of vagus nerve stimulation on emergency department utilization in children with drug-resistant epilepsy: a retrospective cohort study.
Muthiah N; Reecher HM; Abel TJ
J Neurosurg Pediatr; 2024 Jun; ():1-8. PubMed ID: 38905712
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
[TBL] [Abstract][Full Text] [Related]
9. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
Chambers A; Bowen JM
Ont Health Technol Assess Ser; 2013; 13(18):1-37. PubMed ID: 24228081
[TBL] [Abstract][Full Text] [Related]
10. Analysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland).
Kopciuch D; Barciszewska AM; Fliciński J; Zaprutko T; Kus K; Steinborn B; Nowakowska E
Acta Neurol Belg; 2020 Feb; 120(1):115-122. PubMed ID: 31721076
[TBL] [Abstract][Full Text] [Related]
11. Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England.
Camp C; Smithson WH; Bunker M; Burke T; Hughes D
Epilepsy Behav; 2015 Nov; 52(Pt A):68-73. PubMed ID: 26409132
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology.
Xie H; Ma J; Ji T; Liu Q; Cai L; Wu Y
Epilepsy Behav; 2023 Mar; 140():109107. PubMed ID: 36758359
[TBL] [Abstract][Full Text] [Related]
13. Economic and clinical evaluation of vagus nerve stimulation therapy.
Kopciuch D; Barciszewska AM; Fliciński J; Paczkowska A; Winczewska-Wiktor A; Jankowski R; Steinborn B; Nowakowska E
Acta Neurol Scand; 2019 Oct; 140(4):244-251. PubMed ID: 31165476
[TBL] [Abstract][Full Text] [Related]
14. Anterior Nucleus of the Thalamus Deep Brain Stimulation with Concomitant Vagus Nerve Stimulation for Drug-Resistant Epilepsy.
Parisi V; Lundstrom BN; Kerezoudis P; Alcala Zermeno JL; Worrell GA; Van Gompel JJ
Neurosurgery; 2021 Sep; 89(4):686-694. PubMed ID: 34333659
[TBL] [Abstract][Full Text] [Related]
15. Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex.
Tong X; Wang X; Qin L; Zhou J; Guan Y; Teng P; Wang J; Yang Y; Li T; Luan G
Epilepsy Behav; 2022 Jan; 126():108431. PubMed ID: 34883463
[TBL] [Abstract][Full Text] [Related]
16. Hospital costs associated with vagus nerve stimulation and medical treatment in pediatric patients with refractory epilepsy.
Zhang L; Hall M; Lam SK
Epilepsia; 2022 May; 63(5):1141-1151. PubMed ID: 35188675
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy.
Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
Epilepsy Behav; 2011 Oct; 22(2):370-5. PubMed ID: 21872534
[TBL] [Abstract][Full Text] [Related]
18. Comparison of healthcare resource utilization in pediatric patients with refractory epilepsy: Vagus nerve stimulation and medical treatment cohorts.
Zhang L; Wu JY; Lam SK
Epilepsy Behav; 2021 Oct; 123():108281. PubMed ID: 34509035
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug-resistant epilepsy enrolled in a Russian VNS Registry.
Feygina AA; Koshelyaevskaya YN; Dibué M; Voronkova KV; Klochkov MN; Koroleva NY; Ivanov SS; Bolshakova ES; Fatykhova EF
Brain Behav; 2023 Jul; 13(7):e3076. PubMed ID: 37254623
[TBL] [Abstract][Full Text] [Related]
20. The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis.
Hajtovic S; LoPresti MA; Zhang L; Katlowitz KA; Kizek DJ; Lam S
J Neurosurg Pediatr; 2022 Jun; 29(6):667-680. PubMed ID: 35303699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
